CVS

CVS HEALTH CORPORATION

80.58

USD

CVS Earnings Reports

Positive Surprise Ratio

CVS beat 37 of 39 last estimates.

95%

Next Report

Date of Next Report

Feb 10, 2026

Estimate for Q4 25 (Revenue/ EPS)

$104.68B

$0.99

Implied change from Q3 25 (Revenue/ EPS)

+1.76%

-38.13%

Implied change from Q4 24 (Revenue/ EPS)

+7.14%

-16.81%

CVS HEALTH CORPORATION earnings per share and revenue

On Oct 29, 2025, CVS reported earnings of 1.60 USD per share (EPS) for Q3 25, beating the estimate of 1.38 USD, resulting in a 15.69% surprise. Revenue reached 102.87 billion, compared to an expected 99.84 billion, with a 3.04% difference. The market reacted with a -1.95% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 26 analysts forecast an EPS of 0.99 USD, with revenue projected to reach 104.68 billion USD, implying an decrease of -38.13% EPS, and increase of 1.76% in Revenue from the last quarter.

FAQ

What were CVS HEALTH CORPORATION's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, CVS HEALTH CORPORATION reported EPS of $1.60, beating estimates by 15.69%, and revenue of $102.87B, 3.04% above expectations.

How did the market react to CVS HEALTH CORPORATION's Q3 2025 earnings?

The stock price moved down -1.95%, changed from $82.20 before the earnings release to $80.60 the day after.

When is CVS HEALTH CORPORATION expected to report next?

The next earning report is scheduled for Feb 10, 2026.

What are the forecasts for CVS HEALTH CORPORATION's next earnings report?

Based on 26 analysts, CVS HEALTH CORPORATION is expected to report EPS of $0.99 and revenue of $104.68B for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.